Buy me a coffee · $1
×

Support us with a small donation 💝

Every coffee keeps the site running. Thank you!

Clinical Trials Accelerate Deployment of Continuous Biomarker Monitoring Devices

 ·  1 min read

Medical device manufacturers are expanding the scope of wearable biosensors beyond diabetes management into broader metabolic health monitoring. Phase III clinical trials are currently evaluating multi-analyte continuous sensors.

Diagnostic Accuracy
Preliminary trial results indicate that real-time tracking of lactate and cortisol levels alongside glucose offers a 35 percent improvement in early detection of acute metabolic stress. Regulatory submissions are projected for early next year.